User profiles for Nathaniel I. Bloom
 | Nathaniel BloomStanford Immunology Verified email at stanford.edu Cited by 1281 |
[PDF][PDF] SARS-CoV-2 vaccination induces immunological T cell memory able to cross-recognize variants from Alpha to Omicron
We address whether T cell responses induced by different vaccine platforms (mRNA-1273,
BNT162b2, Ad26.COV2.S, and NVX-CoV2373) cross-recognize early SARS-CoV-2 variants. …
BNT162b2, Ad26.COV2.S, and NVX-CoV2373) cross-recognize early SARS-CoV-2 variants. …
[PDF][PDF] Humoral and cellular immune memory to four COVID-19 vaccines
Multiple COVID-19 vaccines, representing diverse vaccine platforms, successfully protect
against symptomatic COVID-19 cases and deaths. Head-to-head comparisons of T cell, B cell, …
against symptomatic COVID-19 cases and deaths. Head-to-head comparisons of T cell, B cell, …
SARS-CoV-2 infection generates tissue-localized immunological memory in humans
Adaptive immune responses to SARS-CoV-2 infection have been extensively characterized
in blood; however, most functions of protective immunity must be accomplished in tissues. …
in blood; however, most functions of protective immunity must be accomplished in tissues. …
A particulate saponin/TLR agonist vaccine adjuvant alters lymph flow and modulates adaptive immunity
Saponins are potent and safe vaccine adjuvants, but their mechanisms of action remain
incompletely understood. Here, we explored the properties of several saponin formulations, …
incompletely understood. Here, we explored the properties of several saponin formulations, …
Memory B-cell development after asymptomatic or mild symptomatic SARS-CoV-2 infection
Background The development of memory B cells after asymptomatic severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2) infection is not well understood. Methods We …
syndrome coronavirus 2 (SARS-CoV-2) infection is not well understood. Methods We …
[PDF][PDF] Asymptomatic or symptomatic SARS-CoV-2 infection plus vaccination confers increased adaptive immunity to variants of concern
The ongoing evolution of SARS-CoV-2 requires monitoring the capability of immune
responses to cross-recognize Variants of Concern (VOC). In this cross-sectional study, we …
responses to cross-recognize Variants of Concern (VOC). In this cross-sectional study, we …
Mpox vaccine and infection-driven human immune signatures: an immunological analysis of an observational study
Background Monkeypox virus has recently infected more than 88 000 people, raising concerns
about our preparedness against this emerging viral pathogen. Licensed and approved …
about our preparedness against this emerging viral pathogen. Licensed and approved …
[HTML][HTML] Preserved SARS-CoV-2 vaccine cell-mediated immunogenicity in patients with inflammatory bowel disease on immune-modulating therapies
Immune-modulating medications for inflammatory bowel diseases (IBDs) have been
associated with suboptimal vaccine responses. There are conflicting data with SARS-CoV-2 …
associated with suboptimal vaccine responses. There are conflicting data with SARS-CoV-2 …
[HTML][HTML] SARS-CoV-2 monoclonal antibody treatment followed by vaccination shifts human memory B cell epitope recognition suggesting antibody feedback
Therapeutic anti-SARS-CoV-2 monoclonal antibodies (mAbs) have been extensively
studied in humans, but the impact on immune memory of mAb treatment during an ongoing …
studied in humans, but the impact on immune memory of mAb treatment during an ongoing …
Mpox vaccine and infection-driven human immune signatures
Background Mpox (formerly known as monkeypox) outbreaks outside endemic areas peaked
in July 2022, infecting > 85,000 people and raising concerns about our preparedness …
in July 2022, infecting > 85,000 people and raising concerns about our preparedness …